bexagliflozin

INN (International Nonproprietary Name)

🇺🇸 Also approved in the US (FDA)

BRENZAVVY — THERACOSBIO, approved 2026-06-03 (NDA214373).

Most reported adverse events (US / FAERS)

66 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.

weight decreased

7

headache

6

nausea

6

cough

5

decreased appetite

Medicines containing this active substance

1 medicines

Bexatil

Opinion

🇺🇸 Also approved in the US (FDA)

BRENZAVVY — THERACOSBIO, approved 2026-06-03 (NDA214373).

Most reported adverse events (US / FAERS)

66 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.

weight decreased

7

headache

6

nausea

6

cough

5

decreased appetite

5

chest discomfort

4

dyspnoea

4

fatigue

4

gastrointestinal disorder

4

oropharyngeal pain

4

throat irritation

4

throat tightness

4

abdominal pain upper

3

asthenia

3

blood glucose increased

3